Reply
Journal
Journal of Hypertension
Journal Volume
35
Journal Issue
12
Pages
2549-2550
Date Issued
2017
Author(s)
Abstract
aDepartment of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Hsinchu County bDepartment of Internal Medicine, National Taiwan University Hospital cTaiwan Primary Aldosteronism Investigation (TAIPAI) Study Group, Taipei, Taiwan Correspondence to Tai-Shuan Lai, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. E-mail: [email protected] Received 5 August, 2017 Accepted 7 August, 2017
SDGs
Other Subjects
adipocytokine; aldosterone; glucocorticoid; glucocorticoid receptor; hydrocortisone; mineralocorticoid antagonist; mineralocorticoid receptor; tissue inhibitor of metalloproteinase 1; hydrocortisone; adipocyte; adrenalectomy; cohort analysis; drug efficacy; heart fibroblast; hormone release; human; hydrocortisone blood level; Letter; long term care; metabolic syndrome X; osteoporosis; prevalence; primary hyperaldosteronism; priority journal; protein binding; protein expression; quality of life; risk factor; Cushing syndrome; diabetes mellitus; hyperaldosteronism; risk; Cushing Syndrome; Diabetes Mellitus; Humans; Hydrocortisone; Hyperaldosteronism; Risk
Publisher
Lippincott Williams and Wilkins
Type
letter